Dr. Tulika Seth, Professor of Hematology at the All India Institute of Medical Science, and Mukesh Garodia, President of the Hemophilia Federation India, discuss how multistakeholder partnerships are helping to inform health policies in India to improve care for the bleeding disorders community.

All information is accurate as of September 2020. This podcast series is initiated, funded, and organized by Takeda. Some speakers were paid an honorarium by Takeda for their participation. Copyright 2020 Takeda Pharmaceutical Company Limited. All rights reserved. Takeda and the Takeda logo are registered trademarks of Takeda Pharmaceutical Company Limited. September 2020 | C-ANPROM/INT//8324

Hosted on Acast. See acast.com/privacy for more information.

Dr. Nguyễn Thị Mai, a hemophilia expert from Vietnam, together with Brian O'Mahony, the CEO of the Irish Haemophilia Society, discuss how two World Federation of Hemophilia (WFH) capacity-building programs have been implemented in Vietnam and the role that each of them has had in improving care for the bleeding disorders community.

All information is accurate as of September 2020. This podcast series is initiated, funded, and organized by Takeda. Some speakers were paid an honorarium by Takeda for their participation. Copyright 2020 Takeda Pharmaceutical Company Limited. All rights reserved. Takeda and the Takeda logo are registered trademarks of Takeda Pharmaceutical Company Limited. September 2020 | C-ANPROM/INT//8265

Hosted on Acast. See acast.com/privacy for more information.

**This episode is only intended for listeners outside the United States**

Dr. Runhui Wu from the Beijing Children’s Hospital in Beijing, China, and Professor Alfonso Iorio from McMaster University, Ontario, Canada, talk about the why and the how of individualized prophylaxis. Barriers to individualized prophylaxis and the effect that this type of treatment plan can have on patient outcomes such as bleeding frequency and joint health are also discussed.

All information is accurate as of September 2020. This podcast series is initiated, funded, and organized by Takeda. Some speakers were paid an honorarium by Takeda for their participation. Copyright 2020 Takeda Pharmaceutical Company Limited. All rights reserved. Takeda and the Takeda logo are registered trademarks of Takeda Pharmaceutical Company Limited. September 2020 | C-ANPROM/INT//8262

Hosted on Acast. See acast.com/privacy for more information.

**This episode is only intended for listeners outside the United States**

Clive Smith from the UK and Ekawat Suwantaroj from Thailand, two patients with severe hemophilia A who chair patient groups in their home countries, compare their own journeys to personalized care. A key point of discussion is the importance of personalized care plans and multidisciplinary teams in supporting patients with hemophilia to reach their own goals.

All information is accurate as of September 2020. This podcast series is initiated, funded, and organized by Takeda. Some speakers were paid an honorarium by Takeda for their participation. Copyright 2020 Takeda Pharmaceutical Company Limited. All rights reserved. Takeda and the Takeda logo are registered trademarks of Takeda Pharmaceutical Company Limited. September 2020 | C-ANPROM/INT//8261

Hosted on Acast. See acast.com/privacy for more information.

Tina Carmillia, a Malaysian multimedia producer and journalist, interviews healthcare professionals, policy makers, and patient representatives from the bleeding disorders community regarding patient advocacy and personalized care.

All information is accurate as of September 2020. This podcast series is initiated, funded, and organized by Takeda. Some speakers were paid an honorarium by Takeda for their participation. Copyright 2020 Takeda Pharmaceutical Company Limited. All rights reserved. Takeda and the Takeda logo are registered trademarks of Takeda Pharmaceutical Company Limited. September 2020 | C-ANPROM/INT//8238

Hosted on Acast. See acast.com/privacy for more information.

This podcast episode brings together three members of the rare bleeding disorders community, Baiba Ziemele, Donal McCann and Clive Smith, for a captivating and informative conversation about their personal experiences, quality of life, current gaps in diagnosis and care, and whether there are key learnings from the hemophilia community that can be applied to von Willebrand disease.

All information is accurate as of September 2020. This stand-alone podcast episode is intended for listeners outside the US only. This podcast is initiated, organized, and funded by Takeda. All speakers were paid an honorarium by Takeda for their participation. Copyright 2020 Takeda Pharmaceutical Company Limited. All rights reserved. Takeda and the Takeda logo are registered trademarks of Takeda Pharmaceutical Company Limited. September 2020 / C-ANPROM/INT//8292

Hosted on Acast. See acast.com/privacy for more information.

This podcast episode brings together three members of the rare bleeding disorders community, Baiba Ziemele, Donal McCann and Clive Smith, for a captivating and informative conversation about their personal experiences, quality of life, current gaps in diagnosis and care, and whether there are key learnings from the hemophilia community that can be applied to von Willebrand disease.

All information is accurate as of September 2020. This stand-alone podcast episode is intended exclusively for delegates of the European Haemophilia Consortium virtual annual conference 2020. This podcast is initiated, organized, and funded by Takeda. All speakers were paid an honorarium by Takeda for their participation. Copyright 2020 Takeda Pharmaceutical Company Limited. All rights reserved. Takeda and the Takeda logo are registered trademarks of Takeda Pharmaceutical Company Limited. September 2020 / C-ANPROM/INT//8292

See acast.com/privacy for privacy and opt-out information.